Stockreport

Generex Biotechnology Partner Regentys Corporation Receives European Patent Approval for ECMH™ for Treatment of Ulcerative Colitis

GENEREX BIOTECHNOLOGY  (GNBT) 
US:NASDAQ Investor Relations: generex.com/investor
PDF Regentys Extracellular Matrix Hydrogel (ECMH™) Advances Regenerative Medicine Approach for Inflammatory Bowel Diseases MIRAMAR, Fla.--(BUSINESS WIR [Read more]